http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008534531-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5015 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5078 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2081 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522 |
filingDate | 2006-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2008-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2008534531-A |
titleOfInvention | Multiparticulate pharmaceutical dosage form with pellets having a matrix that affects the delivery of the modulator |
abstract | The present invention comprises a) optionally a neutral core (non-pareil), b) affects the delivery of modulators and is embedded in a matrix with pharmaceutically usable polymers, waxes, resins and / or proteins. An inner control layer having a regulated substance and optionally an active ingredient, c) an active ingredient layer having a pharmaceutically active ingredient and optionally a regulating substance, d) a (meth) acrylate copolymer An outer control layer having at least 60% by weight of one or several mixtures of the above, wherein said outer control layer has a thickness of less than 20-55 μm and glycerol monostearate is less than 0. 1-10% by weight, a multiparticulate pharmaceutical dosage form has 20-60% by weight of pellets, the pellets are mixed and compressed with 80-40% by weight of the outer phase, Multiparticulate medicine comprising pellets with a multilayered structure for controlled active ingredient release, consisting of 50-100% by weight of cellulose or cellulose derivatives and optionally 0-50% by weight of other pharmaceutical excipients It relates to drug forms. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10328037-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11090279-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10143665-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016523250-A |
priorityDate | 2005-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1081.